14265
Lebrikizumab is a monoclonal anti - IL - 13 antibody that has shown clinical benefit in a phase II study for the treatment of moderate - to - severe uncontrolled asthma .
 None
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Chemical 
Text: {0} 
Answer:
 None